前交叉韧带重建术后患者报告结局量表PASS阈值应用的临床意义
该横断面研究纳入223例前交叉韧带重建术后7.62±1.71个月的患者,比较达到与未达到IKDC、KOOS及ACL-RSI的PASS阈值者在等速肌力与跳跃表现上的差异。达到IKDC PASS和KOOS PASS(疼痛、日常生活活动、运动子量表)者双侧膝力量更大、跳跃更远且更对称;ACL-RSI PASS与肌力无关,但与单腿跳远和三跳远的肢体对称指数更对称相关。作者认为PASS阈值可辅助临床判断患者能否安全重返活动。
要点
- 达到IKDC PASS者膝伸肌LSI为71.64%±15.23%,未达到者为64.66%±17.07%(P<.001)。
- IKDC PASS状态与膝屈肌峰值力矩LSI≥90%显著相关(χ2=9.66,P=.002)。
- ACL-RSI PASS与肌力无关(P>.05),但与单腿跳远和三跳远LSI更对称相关(P<.05)。
核心结论
- 达到IKDC PASS和KOOS PASS(疼痛、日常生活活动、运动子量表)阈值的患者双侧膝力量更大、跳跃更远且更对称。
- 使用PASS阈值可帮助临床医生考虑前交叉韧带重建术后患者何时可安全重返活动。
研究设计与样本
- 横断面研究,证据等级3级,在学术机构的受控实验室环境中进行。
- 共纳入223例前交叉韧带重建术后患者(女106例,男117例;术后7.62±1.71个月)。
- 患者完成90度/秒等速膝伸肌和屈肌力量、跳跃表现(单腿跳远、三跳远、6米计时跳)及患者报告结局量表(IKDC、KOOS、ACL-RSI)评估。
- 采用独立样本t检验比较达到与未达到PASS者的力量和跳跃指标,采用卡方检验比较LSI≥90%的通过状态与PRO PASS状态。
主要发现
- IKDC PASS组膝伸肌ACLR侧1.72±0.47 N·m/kg、对侧2.40±0.45 N·m/kg、LSI 71.64%±15.23%,IKDC FAIL组分别为1.47±0.52 N·m/kg、2.25±0.47 N·m/kg、64.66%±17.07%(P<.001;d=0.3-0.55)。
- IKDC PASS组膝屈肌ACLR侧1.04±0.29 N·m/kg、对侧1.05±0.26 N·m/kg、LSI 99.12%±17.22%,IKDC FAIL组分别为0.88±0.28 N·m/kg、0.97±0.28 N·m/kg、90.46%±17.41%。
- IKDC PASS状态与膝屈肌峰值力矩LSI≥90%(χ2=9.66;P=.002)、单腿跳远(χ2=9.61;P=.002)和三跳远(χ2=3.97;P=.02)显著相关,效应量中等(P<.05;d=0.41-0.73)。
- KOOS PASS(疼痛、日常生活活动、运动子量表)与膝屈肌峰值力矩LSI≥90%显著相关(疼痛和日常生活活动P<.001;运动P=.04;d=0.59-0.72),与单腿跳远在症状子量表上呈强效应量相关(症状P<.01,d=1.21;疼痛P=.003;日常生活活动P=.04;运动P=.001)。
- ACL-RSI PASS组与FAIL组在力量结局上无差异(P>.05);ACL-RSI PASS组单腿跳远和三跳远LSI更对称,且三跳远对侧肢体跳得更远(P<.05;d=0.50-0.64)。
关键数值与推荐
- PASS为基于证据的阈值,用于定义患者可接受的症状状态。
- 肢体对称指数(LSI)计算为(ACLR侧÷对侧)×100%,操作定义LSI≥90%为通过。
- IKDC、KOOS(疼痛、日常生活活动、运动、症状子量表)和ACL-RSI均设有PASS阈值。
临床怎么用
- 作者认为,使用PRO的PASS阈值可帮助临床医生考虑前交叉韧带重建术后患者何时可安全重返活动。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patient-reported outcome (PROs) instruments of knee function quality of life are routinely administered to patients after anterior cruciate ligament reconstruction (ACLR). The Patient Acceptable Symptom State (PASS), an evidence-based threshold defining perceived outcomes, may be a useful indicator of strength and functional performance. PURPOSE: To compare strength and functional performance between patients recovering from ACLR who did and did not meet PASS thresholds on associated PROs. STUDY DESIGN: Cross-sectional study; Level of evidence, 3. METHODS: A total of 223 patients who had undergone ACLR (106 women, 117 men; 7.62 ± 1.71 months after ACLR) completed isokinetic knee extensor and flexor strength at 90 deg/s, hop performance (single-limb hop for distance [SLHD], triple hop for distance [THD], 6-m timed hop [6MH]), and PROs (International Knee Documentation Committee Subjective Form [IKDC], Knee injury and Osteoarthritis Outcome Score [KOOS], and Anterior Cruciate Ligament Return to Sport After Injury [ACL-RSI]) assessments in a controlled laboratory setting at an academic institution. Independent-samples t tests compared strength and hop measures between patients who did and did not achieve a PASS on the PROs. Limb symmetry index (LSI) was calculated as (ACLR Limb ÷ Contralateral Limb) × 100%. Strength and hop performance LSI outcomes were converted into indicator variables, categorized as either a "pass" or "fail" based on the operational definition of having an LSI value ≥90%. Chi-square tests compared strength and hop LSI PASS status measures to PRO PASS status. RESULTS: Patients who achieved IKDCPASS were significantly stronger and had more symmetric limbs than those who did not achieve IKDCPASS. Values for IKDCPASS were as follows: knee extension ACLR limb 1.72 ± 0.47 N·m/kg, contralateral limb 2.40 ± 0.45 N·m/kg, LSI 71.64% ± 15.23%; knee flexion ACLR limb 1.04 ± 0.29 N·m/kg, contralateral limb 1.05 ± 0.26 N·m/kg, LSI 99.12% ± 17.22%. Values for IKDCFAIL were knee extension ACLR limb 1.47 ± 0.52 N·m/kg, contralateral limb 2.25 ± 0.47 N·m/kg, LSI 64.66% ± 17.07%; knee flexion ACLR limb 0.88 ± 0.28 N·m/kg, contralateral limb 0.97 ± 0.28 N·m/kg, LSI 90.46% ± 17.41%. Effect sizes ranged from small to moderate (P < .001; d = 0.3-0.55). IKDCPASS status was significantly associated with an LSI ≥90% for knee flexion peak torque (χ2 = 9.66; P = .002), SLHD (χ2 = 9.61; P = .002), and THD (χ2 = 3.97; P = .02), with a moderate effect size (P < .05; d = 0.41-0.73). Significant relationships were found with KOOSPASS (Pain, Activities of Daily Living [ADL], and Sport) and LSI ≥90% for peak knee flexion torque with a moderate effect size (Pain and ADL, P < .001; Sport, P = .04; d = 0.59-0.72) and SLHD with a strong effect size for the Symptom subscale (Symptom, P < .01, d = 1.21; Pain, P = .003; ADL, P = .04; Sport, P = .001). No differences were found in strength outcomes for patients who achieved ACL-RSIPASS versus those who did not (P > .05). Patients who achieved ACL-RSIPASS had more symmetric SLHD and THD LSI scores and jumped farther on their contralateral limb for the THD compared with ACL-RSIFAIL patients (P < .05; d = 0.50-0.64). CONCLUSION: Patients meeting thresholds for the IKDCPASS and KOOSPASS (Pain, ADL, and Sport subscales) demonstrated greater knee strength bilaterally, and hopped farther and more symmetrically, compared with patients who scored below the PASS threshold on the same PROs. Using PASS thresholds for PROs can aid clinicians when considering when patients can safely return to activities after ACLR.
引用
- Mobley J, Kelly DK, Lauck BJ, et al. The Clinical Significance of Using PASS Thresholds When Administering Patient-Reported Outcome Instruments After Anterior Cruciate Ligament Reconstruction. Am J Sports Med. 2025. PMID: 39745270. doi:10.1177/03635465241298917
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。